Art appreciation is considered essential to human experience. While taste in art varies depending on the individual, cognitive neuroscience can
Home »
Your gut microbiome may be linked to dementia, Parkinson’s disease and MS
Within our body and on our skin, trillions of bacteria and viruses exist as part of complex ecosystems called microbiomes.
Innovative machine-learning approach for future diagnostic advances in Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, with patient numbers being expected to double worldwide in the
Mimicking brain cells to understand Parkinson’s
A device that mimics the brain cells affected by Parkinson’s disease could help find new treatments for the condition. The
Common diabetes drugs may prevent Parkinson’s
Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to
People with Parkinson’s disease can have a brighter future
Well over six million people globally have been diagnosed with Parkinson’s disease, which has an enormous impact on the lives
Could monitoring blood pressure help reduce falls for people with Parkinson’s?
People with Parkinson’s disease are more likely than people of a similar age without the disease to have a sudden
Targeting alpha-synuclein in the gut may slow down Parkinson’s disease
Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of Parkinson’s disease
Big data, bench science suggests drug may slow Parkinson’s progression in people
A drug used to treat enlarged prostate may also be able to slow the progression of Parkinson’s disease. The surprising
Parkinson’s disease: The sign in the skin that could signal the brain condition
Parkinson’s is a progressive neurological condition which means that it causes problems in the brain and gets worse over time.